15 stories about Opioids
קור שולץ מנכ"ל טבע 9.11.19

Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth

08.11.20|Sophie Shulman
CEO Kare Schultz managed over the past three years to keep the boat steady and lessen its debt, but slow growth won’t satisfy investors
קור שולץ מנכ"ל טבע 9.11.19

The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO

19.02.20|Sophie Shulman
Teva’s stock fluctuation is not the result of wrongdoing regarding the U.S. opioid abuse epidemic, but rather something born of the creativity of lawyers, Kåre Schultz said Wednesday at the company’s annual press conference in Tel Aviv
קור שולץ מנכ"ל טבע 9.11.19

Teva Faces U.S. Criminal Probe on Opioid-Related Distribution, Report Says

The Israeli drugmaker is one of six companies to receive subpoenas from federal investigators, the Wall Street Journal reported Tuesday
מטה חברת טבע תרופות

Teva Up 25% on NYSE Since Third Quarter Reports

17.11.19|Sophie Shulman
The Israeli drugmaker closed 8.74% up on Friday after a Cleveland County District judge reduced the fine placed on Johnson and Jonhson in Oklahoma by $107 million, citing a math error made in the original ruling
מטה חברת טבע תרופות

Teva Overcomes One Hurdle, Many Still Ahead

23.10.19|Hezi Sternlicht
The Israeli drugmaker announced on Monday two major achievements regarding the opioid abuse lawsuits against it; but even without taking into consideration its additional legal complications, the settlements it has reached will severely strain its resources
מטה חברת טבע תרופות

Teva Consortium Fails to Reach Opioid Abuse Settlement, Report Says

A $50 billion offer made last week by Teva and the three largest drug distributors in the U.S. does not seem to have panned out, Reuters reported Friday
מטה חברת טבע תרופות

Teva Part of $50 Billion Opioid Settlement Deal, Report Says

17.10.19|Hezi Sternlicht
Teva, a second drugmaker, and the three largest drug distributors in the U.S. have agreed with multiple states on a settlement framework ahead of Monday’s trial, the New York Times reported Thursday
מטה חברת טבע תרופות

Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says

Five of the drugmakers currently battling opioid abuse damages lawsuits in the U.S. are looking to achieve a global settlement through Purdue's bankruptcy case, the Wall Street Journal reported Monday
חברת תרופות אלרגן

Allergan Says Teva Bears Sole Liability for Actavis' Actions

02.09.19|Hezi Sternlicht
Actavis, which Teva bought from Allergan in 2016 for $40.5 billion, was one of the top U.S. sellers of opioids in 2006-2012
מטה חברת טבע תרופות

Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports

28.08.19|Lilach Baumer
Teva, like many other opioid manufacturers operating in the U.S., will be facing multiple opioid abuse-related lawsuits at a trial set to start in October at an Ohio federal court
אתר טבע כפר סבא

Teva Faces New Opioid-Related Lawsuit in West Virginia

25.08.19|Hezi Sternlicht
The lawsuit seems to be unrelated to the trial set to start against Teva and other opioid manufacturers in October in Ohio federal court
מטה חברת טבע תרופות

Teva Jumps on NYSE on a Bit of Good News

21.08.19|Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
אתר טבע כפר סבא

Teva Falls on Pre-Market Trading After Morgan Stanley Downgrade

Teva recently reached an $85 million settlement with the State of Oklahoma regarding its alleged role in the state’s opioid crisis, but is still facing many more claims
מטה חברת טבע תרופות

Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit

27.05.19|Hezi Sternlicht
Teva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation's opioid addiction crisis
מטה חברת טבע תרופות

Teva’s Shady Legal Past Still Weighs on the Debt-Laden Pharma Company

12.05.19|Hezi Sternlicht
On Friday, 43 states joined Connecticut in filing a lawsuit against senior Teva executives and against over a dozen former and current senior executives at leading generic drug companies, alleging all were involved in a drug price-fixing conspiracy